New hope for kids with severe psoriasis: drug trial underway
NCT ID NCT04123795
First seen Nov 11, 2025 · Last updated May 24, 2026 · Updated 19 times
Summary
This study tests a drug called certolizumab pegol in children aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see how the drug works in the body and if it is safe. About 49 participants will receive the drug or a placebo. This is not a cure; the drug aims to control the disease long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE CHRONIC PLAQUE PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ps0007 50156
Arlington, Texas, 76011, United States
-
Ps0007 50161
Los Angeles, California, 90045, United States
-
Ps0007 50162
Fountain Valley, California, 92708, United States
-
Ps0007 50168
Chicago, Illinois, 60611, United States
-
Ps0007 50169
Jacksonville, Florida, 32256, United States
-
Ps0007 50175
Phoenix, Arizona, 85006, United States
-
Ps0007 50183
Calgary, Canada
-
Ps0007 50187
Edmonton, Canada
-
Ps0007 50196
Thousand Oaks, California, 91320, United States
-
Ps0007 50217
Boca Raton, Florida, 33428, United States
-
Ps0007 50225
Calgary, Canada
-
Ps0007 50230
Rome, Georgia, 30161, United States
-
Ps0007 50232
Detroit, Michigan, 48202, United States
-
Ps0007 50248
Hialeah, Florida, 33016, United States
-
Ps0007 50265
San Juan, Puerto Rico
-
Ps0007 50268
Miami, Florida, 33155, United States
-
Ps0007 50269
Wellington, Florida, 33449, United States
-
Ps0007 50277
San Antonio, Texas, 78218, United States
-
Ps0007 50286
Topeka, Kansas, 66614, United States
Conditions
Explore the condition pages connected to this study.